PCT International Application
LOW TEMPERATURE HYPERTHERMIA SYSTEM FOR THERAPEUTIC TREATMENT OF INVASIVE AGENTS
Applicant:
ACTIUM BIOSYSTEMS LLC [US]
Published Aug. 2, 2012
View on Espacenet ↗
| Date | Code | Description | Pages | |
|---|---|---|---|---|
| 2012-05-16 | P.220 |
PCT/ISA/220 - Notification of Transmittal of Search Report and Written Opinion of the ISA, or the Declaration | 1 | View |
| 2012-05-16 | P.210.OUT |
Outgoing - PCT/ISA/210 - International Search Report | 2 | View |
| 2012-05-16 | SRNT |
Examiner's search strategy and results | 4 | View |
| 2012-05-03 | P.220 |
PCT/ISA/220 - Notification of Transmittal of Search Report and Written Opinion of the ISA, or the Declaration | 1 | View |
| 2012-05-03 | P.210.OUT |
Outgoing - PCT/ISA/210 - International Search Report | 2 | View |
| 2012-05-03 | SRNT |
Examiner's search strategy and results | 4 | View |
| 2012-01-19 | P.202.OUT |
Outgoing - PCT/ISA/202 - Notification of Receipt of Search Copy | 1 | View |
| 2012-01-19 | P.102 |
PCT/RO/102 - Notification Concerning Payment of Prescribed Fees and Annex | 2 | View |
| 2012-01-19 | P.105 |
PCT/RO/105 - Notification of the International Application Number and of the International Filing Date | 1 | View |
| 2012-01-19 | P.132 |
DO NOT USE --- RO/132 - Communication in Cases | 1 | View |
| 2011-12-30 | P.SAFE.LOG |
PCT EASY Validation Log | 1 | View |
| 2011-12-30 | SPEC |
Specification | 28 | View |
| 2011-12-30 | CLM |
Claims | 6 | View |
| 2011-12-30 | ABST |
Abstract | 1 | View |
| 2011-12-30 | DRW |
Drawings-only black and white line drawings | 18 | View |
| 2011-12-30 | WFEE |
Fee Worksheet (SB06) | 2 | View |
| 2011-12-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
| 2011-12-30 | P.N.101.ANX |
PCT/RO/101 Annex (fee calculation sheet) | 2 | View |
| 2011-12-30 | P.N.101.SAFE |
PCT/RO/101 - Request form for new International Application - PCT EASY Format | 5 | View |
Abstract
The Low Temperature Hyperthermia System illuminates nano-particles, which are implanted in a living organism at the locus of the cancer or into the cancer cells, with a precisely determined energy field. This energy field ensures that the optimal cancer cell and cancer stem cell destruction temperature of 42C is not exceeded in the tissue, which minimizes the release of Heat Shock Proteins and cancer stem cells. The Low Temperature Hyperthermia System uses specially designed nano-particles that exhibit a specific temperature rise in a given illumination energy field and then have no further temperature rise even if the applied illumination energy field increases beyond the optimal level. Alternatively, the nano-particles exhibit a tightly controlled temperature rise based on a pre-determined illumination energy field strength. This innovative approach can also use radiation and/or chemotherapy in conjunction with the nano-particle illumination to kill the majority of the cancer cells.
Applicants
IPC Classification
A61K 9/ 14 A I
B82Y 5/ 00 A I
US
13/12,572
Filed 2011-01-24
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copy
Most orders are placed same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this PCT's details
Quick Facts
- PCT No.
- PCT/US2011/068154
- Pub. No.
- WO2012102821
- Filed
- Dec. 30, 2011
- Published
- Aug. 2, 2012